Guardian Technologies International, Inc. Enters $2.5 Billion Worldwide Tuberculosis Pathology Market

HERNDON, Va.--(BUSINESS WIRE)--Guardian Technologies International, Inc. (OTCBB:GDTI), announced today further developments in its Agreements with the Aurum Institute for Health Research in South Africa. Based on the broadly reviewed results of Guardian’s product prototype for sputum analysis, using Signature Mapping™ capabilities for the automated detection and quantification of Tuberculosis, Guardian has expanded its relationship with Aurum to include collaboration on product development and commercialization, as well as marketing and distribution rights in South Africa. It is anticipated that Aurum’s distribution rights will extend to additional automated pathology products developed as a result of this collaboration, as well as additional international markets. Aurum will be responsible for the marketing, sales, installation, training and ongoing customer support within its geographical markets.